Compare AZN & MUFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AZN | MUFG |
|---|---|---|
| Founded | 1992 | 1880 |
| Country | United Kingdom | Japan |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 250.7B | 246.3B |
| IPO Year | 1995 | 2002 |
| Metric | AZN | MUFG |
|---|---|---|
| Price | $171.44 | $21.06 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 12 | 2 |
| Target Price | ★ $207.16 | $22.27 |
| AVG Volume (30 Days) | 2.4M | ★ 2.6M |
| Earning Date | 10-30-2026 | 11-13-2026 |
| Dividend Yield | 1.87% | ★ 2.07% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $7.94 | $16.19 |
| Revenue Next Year | $6.26 | $11.90 |
| P/E Ratio | $31.91 | ★ $25.47 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $80.48 | $14.86 |
| 52 Week High | $212.71 | $24.26 |
| Indicator | AZN | MUFG |
|---|---|---|
| Relative Strength Index (RSI) | 62.32 | 31.40 |
| Support Level | $154.70 | $19.65 |
| Resistance Level | $175.04 | $21.18 |
| Average True Range (ATR) | 3.14 | 0.32 |
| MACD | 1.44 | -0.13 |
| Stochastic Oscillator | 87.44 | 7.99 |
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
Mitsubishi UFJ Financial Group is the largest bank in Japan in terms of market capitalization and assets. It is the largest non-Chinese bank group globally and has a balance sheet slightly larger than those of JPMorgan Chase and HSBC Holdings. MUFG's operations in Japan account for around half of profit, banking in Thailand and Indonesia for around 15%, and equity-method earnings from Morgan Stanley most of the rest.